WECARELIFE
LIVE

Serial Number

98338379

Owner

WeCareLife Biotech Co., Ltd.

Attorney

Bharati Bakshani

Filing Date

Jan 2, 2024

Add to watchlist:

No watchlists yet
View on USPTO

WECARELIFE Trademark

Serial Number: 98338379

WECARELIFE is a trademark filed by WeCareLife Biotech Co., Ltd. on January 2, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

WeCareLife Biotech Co., Ltd.

Room 409-143, Floor 4, Building 1,
Daxing, Beijing 102629 , CN

Entity Type: 99

Trademark Details

Filing Date

January 2, 2024

Registration Date

Not Registered

Published for Opposition

September 10, 2024

Goods & Services

Delivery agents in the form of nanoparticles that facilitate the delivery of nutritional supplements; Drug delivery agents in the form of nanoparticles that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 18, 2026 EXRA
SOU EXTENSION 3 GRANTED
Apr 17, 2026 EX3G
SOU EXTENSION 3 FILED
Apr 17, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 17, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 17, 2025 EXRA
SOU EXTENSION 2 GRANTED
Oct 16, 2025 EX2G
SOU EXTENSION 2 FILED
Oct 16, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 16, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 22, 2025 EXRA
SOU EXTENSION 1 GRANTED
Apr 21, 2025 EX1G
SOU EXTENSION 1 FILED
Apr 21, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 21, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 5, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 10, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 10, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 21, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 1, 2024 CNSA
ASSIGNED TO EXAMINER
Jul 30, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 16, 2024 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 16, 2024 NWOS
NEW APPLICATION ENTERED
Jan 2, 2024 NWAP